Incyte Corp. (INCY)
114.05
+1.32
(+1.17%)
USD |
NASDAQ |
Oct 07, 12:39
Incyte 1 Year Total Returns (Daily) : 29.23% for Oct. 6, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 06, 2026 | 29.23% |
| October 05, 2026 | 31.41% |
| October 02, 2026 | 33.63% |
| October 01, 2026 | 35.11% |
| September 30, 2026 | 43.08% |
| September 29, 2026 | 46.86% |
| September 28, 2026 | 50.93% |
| September 25, 2026 | 51.71% |
| September 24, 2026 | 47.86% |
| September 23, 2026 | 47.43% |
| September 22, 2026 | 49.81% |
| September 21, 2026 | 44.05% |
| September 18, 2026 | 45.71% |
| September 17, 2026 | 50.50% |
| September 16, 2026 | 48.69% |
| September 15, 2026 | 46.43% |
| September 14, 2026 | 47.04% |
| September 11, 2026 | 40.97% |
| September 10, 2026 | 42.93% |
| September 09, 2026 | 47.21% |
| September 08, 2026 | 43.72% |
| September 04, 2026 | 48.35% |
| September 03, 2026 | 47.19% |
| September 02, 2026 | 49.84% |
| September 01, 2026 | 47.75% |
| Date | Value |
|---|---|
| August 31, 2026 | 45.63% |
| August 28, 2026 | 48.59% |
| August 27, 2026 | 50.57% |
| August 26, 2026 | 52.52% |
| August 25, 2026 | 53.04% |
| August 24, 2026 | 50.49% |
| August 21, 2026 | 47.71% |
| August 20, 2026 | 47.59% |
| August 19, 2026 | 50.33% |
| August 18, 2026 | 45.40% |
| August 17, 2026 | 42.08% |
| August 14, 2026 | 39.46% |
| August 13, 2026 | 40.38% |
| August 12, 2026 | 47.98% |
| August 11, 2026 | 52.89% |
| August 10, 2026 | 55.06% |
| August 07, 2026 | 54.17% |
| August 06, 2026 | 52.45% |
| August 05, 2026 | 54.13% |
| August 04, 2026 | 54.54% |
| August 03, 2026 | 56.67% |
| July 31, 2026 | 59.59% |
| July 30, 2026 | 58.59% |
| July 29, 2026 | 64.26% |
| July 28, 2026 | 85.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 26.81% |
| Mirum Pharmaceuticals, Inc. | 9.27% |
| Vertex Pharmaceuticals, Inc. | 24.67% |
| Alnylam Pharmaceuticals, Inc. | -50.46% |
| AbbVie, Inc. | 19.46% |